Cody A Moore

Title: Cody A. Moore: Innovator in Engineered Polypeptides

Introduction

Cody A. Moore is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. His innovative work has the potential to impact various applications in medical research and therapeutic development.

Latest Patents

Cody A. Moore holds a patent for "Engineered CD25 polypeptides and uses thereof." This patent provides engineered polypeptides that comprise a combination of spatially-associated topological constraints, with at least one constraint derived from a CD25 reference target. The patent also outlines methods for selecting these engineered polypeptides and their applications as positive and/or negative selection molecules in screening libraries of binding molecules, such as antibodies. Additionally, it includes CD25 antibodies selected using these engineered polypeptides.

Career Highlights

Cody A. Moore is associated with Ibio Limited, where he continues to advance his research and development efforts. His work focuses on innovative solutions that leverage engineered polypeptides for various applications in the biomedical field.

Collaborations

Cody collaborates with notable colleagues, including Matthew Paul Greving and Phung Tu Gip. Their combined expertise contributes to the advancement of their projects and the overall success of their research initiatives.

Conclusion

Cody A. Moore is a key figure in the field of engineered polypeptides, with a patent that showcases his innovative approach to biotechnology. His contributions are paving the way for new advancements in medical research and therapeutic applications.